# A Bioequivalence Study Between Two Nicotine Replacement Therapies in Adult Healthy Smokers Motivated to Quit.

> **NCT03130179** · PHASE1 · COMPLETED · sponsor: **McNeil AB** · enrollment: 244 (actual)

## Conditions studied

- Tobacco Dependence

## Interventions

- **DRUG:** Nicorette Strongmint lozenge 4 mg
- **DRUG:** Niquitin MiniMint lozenge 4 mg

## Key facts

- **NCT ID:** NCT03130179
- **Lead sponsor:** McNeil AB
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-03-20
- **Primary completion:** 2017-06-19
- **Final completion:** 2017-06-29
- **Target enrollment:** 244 (ACTUAL)
- **Last updated:** 2018-07-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03130179

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03130179, "A Bioequivalence Study Between Two Nicotine Replacement Therapies in Adult Healthy Smokers Motivated to Quit.". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT03130179. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*